Is Rvl Pharmaceuticals Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: RVLP) stock is to Strong Buy RVLP stock.
Out of 2 analysts, 1 (50%) are recommending RVLP as a Strong Buy, 1 (50%) are recommending RVLP as a Buy, 0 (0%) are recommending RVLP as a Hold, 0 (0%) are recommending RVLP as a Sell, and 0 (0%) are recommending RVLP as a Strong Sell.
What is RVLP's forecast return on equity (ROE) for 2023-2026?
(NASDAQ: RVLP) forecast ROE is N/A, which is considered weak.
What is RVLP's Price Target?
According to 2 Wall Street analysts that have issued a 1 year RVLP price target, the average RVLP price target is $2.50, with the highest RVLP stock price forecast at $3.00 and the lowest RVLP stock price forecast at $2.00.
On average, Wall Street analysts predict that Rvl Pharmaceuticals's share price could reach $2.50 by Aug 21, 2024. The average Rvl Pharmaceuticals stock price prediction forecasts a potential upside of 2,400% from the current RVLP share price of $0.10.
What is RVLP's forecast return on assets (ROA) for 2023-2026?
(NASDAQ: RVLP) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.07%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.